Gastrointestinal hormones as potential adjuvant treatment of exocrine pancreatic adenocarcinoma

By Fisher William   Muscarella Peter   Boros Laszlo   Schirmer William  

International Journal of Gastrointestinal Cancer, Vol. 24, Iss. 3, 1998-12 ,pp. : 169-180

Humana Press, Inc

Access to resources Recommend Favorite

Safety and efficacy of neoadjuvant FOLFIRINOX treatment in a series of patients with borderline resectable pancreatic ductal adenocarcinoma

By Tinchon Christoph  

Acta Oncologica, Vol. 52, Iss. 6, 2013-08 ,pp. : 1231-1233

Informa Healthcare

Access to resources Recommend Favorite

Borderline Resectable/Locally Advanced Pancreatic Adenocarcinoma: Improvements Needed in Population-Based Registries

By Miura John   Evans Douglas   Pappas Sam   Gamblin T.   Turaga Kiran  

Annals of Surgical Oncology, Vol. 20, Iss. 13, 2013-12 ,pp. : 4338-4347

Springer Publishing Company

Access to resources Recommend Favorite

Immunological Impact of Neoadjuvant Chemoradiotherapy in Patients with Borderline Resectable Pancreatic Ductal Adenocarcinoma

By Homma Yuki   Taniguchi Koichi   Murakami Takashi   Nakagawa Kazuya   Nakazawa Masatoshi   Matsuyama Ryusei   Mori Ryutaro   Takeda Kazuhisa   Ueda Michio   Ichikawa Yasushi   Tanaka Kuniya   Endo Itaru  

Annals of Surgical Oncology, Vol. 21, Iss. 2, 2014-02 ,pp. : 670-676

Springer Publishing Company

Access to resources Recommend Favorite

Current state of adjuvant therapy in resected pancreatic adenocarcinoma

By Bergenfeldt Magnus   Albertsson Maria  

Acta Oncologica, Vol. 45, Iss. 2, 2006-03 ,pp. : 124-135

Informa Healthcare

Access to resources Recommend Favorite